Parke-Davis team achieves excellent preclinical results with new EGF receptor TK inhibitor April 13, 1999
Chemical modification of magainin peptide results in effective, nontoxic antitumor compound April 13, 1999
D-24851 --a new tubulin-interacting agent with oral activity and improved therapeutic index April 13, 1999
RSS